Saddled with the high cost of emerging specialty drugs, employers are looking to their benefit advisers for strategies to manage their medical plans drug spend.
Several factors, including the economy and technological advances, are contributing to a slowdown in the health care cost growth rate in the U.S., studies show.
A nearly 7% spike in health care costs in 2015 can be attributed to a revitalized economy, the modernization of health care technology and the drastic increase in specialty drug use.
The accessibility of specialty prescription drugs may be as elusive on the Affordable Care Acts health care exchanges as it typically has been off of the exchanges, and trusted advisers need to be able to navigate both discussions with clients.
Auditing fees may not be inconsequential, but the fact is that an accurate audit including both pharmacy and medical claims has the potential to pay back the investment many times over.
With the impact of health care reform still evolving, employers are taking a fresh look at their strategies for keeping employees healthy and productive.
Individuals could pay more than twice as much for prescription drugs with certain exchange plans, as employers that provide health coverage gain another asset to leverage.
Unbeknownst to your clients, prescription drugs are likely costing them a great deal. As their trusted adviser, heres how you can help.
In a first look at pharmacy trends in public health insurance exchange plans, use of specialty medications was greater among exchange enrollees versus patients enrolled in a commercial health plan, according to new research released by Express Scripts.
Pharmacy benefits are typically the most utilized benefit by plan members and one of the fastest-growing in terms of cost. Consequently, selecting the right pharmacy benefit manager is a critical decision in managing a plan and determining member satisfaction with that plan.
Overall spending on traditional prescription drugs -- mostly pills used to treat common conditions such as high cholesterol and depression -- will decline 4% by the end of 2015, largely because of the availability of generic medications, according Express Scripts. Here are 10 of the top brand-name drugs that had generic equivalents become available in 2013 or are expected to have generics available this year, courtesy of Express Scripts.
Copayments and co-insurance fees have increased on average 34% compared with those of the pre-Affordable Care Act individual insurance market, according to the results of a new HealthPocket study released Thursday.
A group of Catholic health and educational organizations dont have to comply with a federal Affordable Care Act requirement to provide their employees with contraception coverage, a federal judge in New York ruled.
Expenditures in the $2.7 trillion U.S. health care system have doubled since 1980, growing to 18% of gross domestic product and leading to financial success for drugmakers, hospitals and insurers.
Consumers are happier with brick-and-mortar pharmacies than with mail-order.